The Technical Analyst
Select Language :
Dare Bioscience Inc [DARE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Dare Bioscience Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Dare Bioscience Inc is listed at the  Exchange

-6.74% $0.512

America/New_York / 28 mar 2024 @ 14:54


Dare Bioscience Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 50.46 mill
EPS: -0.480
P/E: -1.070
Earnings Date: Mar 28, 2024
SharesOutstanding: 98.56 mill
Avg Daily Volume: 0.420 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.070 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.18x
Company: PE -1.070 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.254
(144.86%) $0.742
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.461 - 0.563

( +/- 9.96%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-12 Fair John A Buy 290 000 Employee Stock Option (right to buy)
2024-03-12 Johnson Sabrina Martucci Buy 750 000 Employee Stock Option (right to buy)
2024-03-12 Haring-layton Mardee Buy 290 000 Employee Stock Option (right to buy)
2024-01-26 Haring-layton Mardee Sell 3 500 Employee Stock Option (right to buy)
2024-01-26 Haring-layton Mardee Sell 30 000 Employee Stock Option (right to buy)
INSIDER POWER
79.17
Last 91 transactions
Buy: 10 072 923 | Sell: 492 500

Forecast: 16:00 - $0.512

Live Trading Signals (every 1 min)

Forecast 1: 15:03 - $0.510
Forecast 2: 15:53 - $0.515
Forecast 3: 16:00 - $0.512
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.512 (-6.74% )
Volume 0.477 mill
Avg. Vol. 0.420 mill
% of Avg. Vol 113.64 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Dare Bioscience Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Dare Bioscience Inc

RSI

Intraday RSI14 chart for Dare Bioscience Inc

Last 10 Buy & Sell Signals For DARE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Dare Bioscience Inc

DARE

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
BTC.BUSDMar 28 - 14:5270 463
ESUSDMar 28 - 14:435 305.50
ATMUSDMar 28 - 14:51$3.40
BNBXUSDMar 28 - 14:49628.11
STETHUSDMar 28 - 14:503 534.16
OPUSDMar 28 - 14:493.69
PROMUSDMar 28 - 14:49$14.02
KLAYUSDMar 28 - 14:50$0.268
GLMRUSDMar 28 - 14:500.504
ICXUSDMar 28 - 14:49$0.360

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.